IPO - Haoxin Holdings Ltd

Form Type: 424B4

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: New

Accession Number: 000121390025032325

Filing Summary: Haoxin Holdings Limited is conducting an initial public offering of 1,750,000 Class A ordinary shares priced at $4.00 per share, aiming to raise approximately $7 million. The shares will trade on the Nasdaq Capital Market under the symbol 'HXHX'. The company is a Cayman Islands holding company that does not have material operations, relying instead on its subsidiaries in the People's Republic of China (PRC). The document outlines the capital structure, detailing different voting rights between Class A and Class B shares, and emphasizes the risks associated with investing in companies operating under Chinese regulations. The IPO is classified as an indirect offering, necessitating PRC regulatory filings, and the company states it has complied with all necessary procedures, including those set by the China Securities Regulatory Commission (CSRC). It mentions regulatory risks from the evolving legal and operational landscape in China that could impact operations and shareholder value. Furthermore, the company is considered an 'emerging growth company' under U.S. law, which allows it to benefit from reduced reporting obligations. Investors are warned about various market and legal risks, including difficulties associated with foreign investments in PRC firms.

Form Type: F-1/A

Filing Date: 2025-03-18

Corporate Action: Ipo

Type: New

Accession Number: 000101376225000652

Filing Summary: Haoxin Holdings Limited is filing an amendment to its registration statement for an initial public offering (IPO) of 1,750,000 Class A ordinary shares. The shares are being offered at a price between $4.00 and $6.00 per share. The company is incorporated in the Cayman Islands and will list its shares on The Nasdaq Capital Market under the symbol 'HXHX.' This registration is part of an ongoing offering process. Prior to this offering, there has been no public market for these shares. Haoxin's corporate structure is a direct holding structure with operations conducted primarily through its subsidiaries in the People's Republic of China (PRC). It has clarified its compliance with PRC regulations regarding overseas listing and has submitted necessary filings to the China Securities Regulatory Commission (CSRC). The company has not received any objections from PRC authorities regarding its plans to list on a U.S. exchange. New regulations in China create uncertainty regarding future foreign investments and operational continuity, but the company has confirmed it is not currently subject to audit inspection issues that could prohibit shares from trading in the U.S.

Form Type: F-1/A

Filing Date: 2025-03-05

Corporate Action: Ipo

Type: New

Accession Number: 000121390025020636

Filing Summary: Haoxin Holdings Limited filed an Amendment No. 13 to Form F-1 with the SEC on March 5, 2025, indicating its initial public offering (IPO) of 1,750,000 Class A ordinary shares. The offering price is expected to range between $4.00 and $6.00 per share. Prior to this offering, there has been no public market for these shares. The company has applied to list its shares on Nasdaq under the symbol 'HXHX'. The company operates through subsidiaries primarily in China and has specified that investors will not hold equity interests in its PRC operating entities. The prospectus includes risk factors highlighting potential challenges due to regulatory changes in China, cybersecurity measures, and the governing laws affecting its operations. Haoxin Holdings Limited emphasizes that no inquiries or sanctions have been received from the China Securities Regulatory Commission regarding its planned overseas listing, although the regulatory landscape remains uncertain. The structure of its cash flows and equity interests within the organization has been clarified, ensuring compliance with PRC laws for the transfer of funds and dividend distributions, though the company does not plan to pay dividends in the immediate future.